Systematic review of Alzheimer's Disease (AD) biomarker studies in those with intellectual and developmental disability (I/DD): Evidence gap mapping
The lack of data from representative samples of individuals with I/DD limits the generalizability of current study outcomes. Future studies should include a broader range of I/DD presentations. In addition to non-DS I/DD presentations, sex differences and novel biomarkers such as beta synuclein and VAMP-2 are promising future directions.
Authors
- Ney Alliey‐Rodriguez (ORCID: https://orcid.org/0000-0001-8594-5676)
- Lubnaa Abdullah (ORCID: https://orcid.org/0000-0002-3664-1075)
- Gladys Elena Maestre (ORCID: https://orcid.org/0000-0001-5690-8833)
- Emma Elizondo
- Ney Alexander Alliey
- James Hall
Institutions
- University of North Texas (US)
- University of North Texas Health Science Center (US)
- The University of Texas Rio Grande Valley (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_106296
- Primary Topic
- Down syndrome and intellectual disability research
- Type
- article
- Field-Weighted Citation Impact
- 0.00